Dr. Gary R. Lichtenstein, MD

Dr. Lichtenstein practices at Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania, part of University of Pennsylvania.

Dr. Lichtenstein's NPI, 1700890720, was assigned on July 27, 2006. Dr. Lichtenstein graduated from Icahn School of Medicine at Mount Sinai in 1984. Dr. Lichtenstein holds Pennsylvania license MD036894E.

Dr. Lichtenstein's primary practice is Hospital of the University of Pennsylvania, at 3400 Spruce St, Philadelphia, PA 19104 in Philadelphia County. The practice phone is (215) 662-6289.

Dr. Lichtenstein's primary practice is Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania, part of University of Pennsylvania. Dr. Lichtenstein is also affiliated with Penn Presbyterian Medical Center. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Lichtenstein to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lichtenstein practices, 6 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Lichtenstein's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Lichtenstein is licensed in Pennsylvania.

CMS data shows 787 Medicare services from Dr. Lichtenstein across 11 procedure codes in 2024, for 363 Medicare patients. Medicare paid $62,431 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 363 Medicare patients who saw Dr. Lichtenstein in 2024. The largest group is 65 to 74, with 176 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lichtenstein's median patient age at 63, with 53% women.

In 2024, Dr. Lichtenstein wrote 958 Medicare Part D claims for 188 patients. 57% of them were for generic drugs. CMS names the drug for 810 of them, across 21 drugs with 11 or more claims each, at $5,309,709 in total drug cost. In 2023, CMS named 676 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Lichtenstein for performance year 2024, reported as part of a group. Dr. Lichtenstein accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lichtenstein as offering telehealth. CMS counts 79 procedures of colonoscopy by Dr. Lichtenstein, more than 74% of the clinicians it reports for that procedure.

Dmand AI links 129 papers to Dr. Lichtenstein, published from 2006 to 2025. 2018 was the busiest year, with 6. The most frequent topics are Colitis, Ulcerative, Crohn Disease and Inflammatory Bowel Diseases. Dr. Lichtenstein has published most often in Inflamm Bowel Dis. Dr. Lichtenstein's most frequent co-authors are William J. Sandborn, MD, Wojciech Blonski, MD, PhD and Bruce Eric Sands, MD.

CMS Open Payments shows 392 general payments to Dr. Lichtenstein from 20 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 74% of the total. Janssen Pharmaceuticals, Inc paid the most, $106,183. It also lists 34 research payments totaling $45,170 from 2018 to 2025.

Dr. Lichtenstein graduated from Icahn School of Medicine at Mount Sinai in 1984.